PBYI
Puma Biotechnology Sees Continued Growth and Progress in Q3 2026
Puma Biotechnology, a leading biopharmaceutical company, released its earnings results for the third quarter of 2026, showcasing continued growth and progress across various fronts. According to Alan Auerbach, Chief Executive Officer, President, and Chairman of the Board of Puma Biotechnology, the company reported total revenue of $55.1 million in